Clinical Trials Browser

Phase 2 × Breast Neoplasms × In Situ Hybridization, Fluorescence × Clear all

NCT00611715 2012-08-09

Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer.

Phase 2 Terminated

48 enrolled 11 charts

Breast Neoplasms